Form 4: AbbVie Director Susan E. Quaggin Reports Acquisition of 1,322 Shares of Common Stock

Director Susan E. Quaggin reports acquiring 1,322 shares of AbbVie common stock on May 3, 2024, through restricted stock units.

Summary

• On May 3, 2024, Susan E. Quaggin, a director of AbbVie Inc., acquired 1,322 shares of AbbVie common stock.
• The acquisition was made through the award of restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These restricted stock units will be paid out in shares of AbbVie common stock on a one-to-one basis upon the director's separation from service, death, or a change in control.
• Following the transaction, Ms. Quaggin directly owns 1,322 shares of AbbVie common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard disclosure of stock acquisition by a director. It doesn't inherently indicate positive or negative sentiment, but insider buying is often viewed as a positive signal.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units will be paid out in shares of AbbVie common stock on a one-to-one basis upon the director's separation from service, death, or a change in control.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates